Total Clarity Wealth Management, Inc. Allogene Therapeutics, Inc. Transaction History

Total Clarity Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$7.65 - $15.29 $1,759 - $3,516	-230 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$21.01 - $27.64 $4,832 - $6,357	230 New	230 $6,000
Q2 2021 Jul 26, 2021	SELL	$23.49 - $35.8 $5,402 - $8,234	-230 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$25.79 - $39.02 $5,931 - $8,974	230 New	230 $8,000

163

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $269M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.